Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy

Journal of Clinical Oncology

Volumn 28, Issue 9, 2010, Pages 1611-1615

  Canellos, George P ^a   Abramson, Jeremy S ^a   Fisher, David C ^a   LaCasce, Ann S ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ABVD PROTOCOL; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CARDIOTOXICITY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DRUG UPTAKE; DRUG WITHDRAWAL; FEMALE; HEART INFARCTION; HODGKIN DISEASE; HUMAN; KAPLAN MEIER METHOD; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION INJURY; SALVAGE THERAPY; SECOND CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; DACARBAZINE; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; MALE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; VINBLASTINE; YOUNG ADULT;

EID: 77951925455     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.3260     Document Type: Article

References (22)

1. Koontz BF, Kirkpatrick JP, Clough RW, et al: Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: Cure balanced against complications. J Clin Oncol 24:605-611, 2006 (Pubitemid 46630423)
2. Bonadonna G, Bonfante V, Viviani S, et al: ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Longterm results. J Clin Oncol 22:2835-2841, 2004 (Pubitemid 41079901)
3. Engert A, Schiller P, Josting A, et al: Involvedfield radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with earlystage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3601-3608, 2003 (Pubitemid 46594052)
4. Specht LR, Gray RG, Clarke MJ, et al: Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: A meta-analysis of 23 randomized trials involving 3,888 patients - International Hodgkin's Disease Collaborative Group. J Clin Oncol 16:830-843, 1998 (Pubitemid 28108714)
5. Fermé C, Eghbali H, Meerwaldt JH, et al: Chemotherapy plus involved-field radiation in earlystage Hodgkin's disease. N Engl J Med 357:1916-1927, 2007
6. Aleman BMP, van den Belt-Dusebout A, De Bruin ML, et al: Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109:1878-1886, 2007
7. Heidenreich PA, Schnittger I, Strauss HW, et al: Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 25:43-49, 2007 (Pubitemid 350003049)
8. Franklin J, Pluetschow A, Paus M, et al: Second malignancy risk associated with treatment of Hodgkin's lymphoma: Meta-analysis of the randomised trials. Ann Oncol 17:1749-1760, 2006 (Pubitemid 44884048)
9. Hodgson DC, Gilbert ES, Dores GM, et al: Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 25:1489-1497, 2007 (Pubitemid 46759253)
10. Boleti E, Mead GM: ABVD for Hodgkin's lymphoma: Full-dose chemotherapy without dose reductions or growth factors. Ann Oncol 18:376-380, 2007 (Pubitemid 46323108)
11. Rueda Domínguez A, Márquez A, Gumá J, et al: Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: Results after 7 years of a prospective study. Ann Oncol 15:1798-1804, 2004
12. Straus DJ, Portlock CS, Qin J, et al: Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stage I, II, and IIIA non-bulky Hodgkin disease. Blood 104:3483-3489, 2004 (Pubitemid 39564416)
13. Meyer RM, Gospodarowicz MK, Connors JM, et al: Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology group. J Clin Oncol 23:4623-4642, 2005
14. Ng AK, Bernardo MP, Weller E, et al: Longterm survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 20:2101-2108, 2002 (Pubitemid 34408801)
15. Longo DL, Glatstein E, Duffey PL, et al: A prospective trial of radiation alone vs. combination chemotherapy alone for early-stage Hodgkin's disease: Implications of 25-year follow-up to current combined modality therapy. Blood 108:33a, 2006 (abstr 398)
16. Barnes JA, LaCasce AS, Toomey CE, et al: Early interim FDG-PET predicts outcome in nonbulky limited stage Hodgkin lymphoma but may not guide use of consolidative radiotherapy. Blood 112: 518A, 2008
17. Sieniawski M, Franklin J, Nogova L, et al: Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma. J Clin Oncol 25:2000-2005, 2007
18. Engert A, Franklin J, Eich HT, et al: Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: Final results of the GHSG HD7 trial. J Clin Oncol 25:3495-3502, 2007 (Pubitemid 47310889)
19. Pavone V, Ricardi U, Luminari S, et al: ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: Results from an Intergrouppo Italiano Linfomi randomized study. Ann Oncol 19:763-768, 2008 (Pubitemid 351461049)
20. Bonadonna G, Viviani S, Bonfante V, et al: Survival in Hodgkin's disease patients: Report of 25 years of experience at the Milan Cancer Institute. Eur J Cancer 41:998-1006, 2005 (Pubitemid 40602851)
21. Canellos GP, Duggan D, Johnson J, et al: How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen? J Clin Oncol 22:1532-1533, 2004
22. Swerdlow AJ, Higgins CD, Smith P, et al: Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British Cohort Study. J Natl Cancer Inst 99:206-214, 2007